# FDA recall D-0536-2023

> **Amerisource Health Services LLC** · Class II · drug recall initiated 2023-03-16.

## Product

Verapamil Hydrochloride Extended-Release Tablets, USP, 180 mg, 100 Tablets (10 x 10) per carton, Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217.  NDC Carton: 60687-504-01; NDC Unit Dose: 60687-504-11, barcode (01) 003 60687 504 11 7.

## Reason for recall

Failed Dissolution Specifications: Out of specification dissolution results above specified values.

## Distribution

Nationwide in the USA

## Key facts

- **Recall number:** D-0536-2023
- **Recalling firm:** Amerisource Health Services LLC
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2023-03-16
- **Report date:** 2023-04-26
- **Termination date:** 2024-05-12

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Columbus, OH, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0536-2023

## Citation

> AI Analytics. FDA recall D-0536-2023. Retrieved 2026-07-20 from https://api.ai-analytics.org/recall/D-0536-2023. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*